Lawson Kroeker Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,723
Closed -$768K 64
2025
Q3
$768K Hold
2,723
0.14% 70
2025
Q2
$760K Sell
2,723
-202
-7% -$57.2K 0.14% 71
2025
Q1
$911K Hold
2,925
0.17% 66
2024
Q4
$762K Sell
2,925
-145
-5% -$43K 0.14% 70
2024
Q3
$989K Hold
3,070
0.18% 65
2024
Q2
$959K Buy
3,070
+26
+0.9% +$7.64K 0.19% 65
2024
Q1
$865K Buy
3,044
+350
+13% +$102K 0.16% 67
2023
Q4
$776K Hold
2,694
0.16% 71
2023
Q3
$724K Hold
2,694
0.16% 70
2023
Q2
$598K Sell
2,694
-150
-5% -$34.8K 0.14% 68
2023
Q1
$688K Buy
+2,844
New +$698K 0.15% 73

Other funds holding AMGN

Lawson Kroeker Investment Management's AMGN Position: Q4 2025 in Review

Lawson Kroeker Investment Management sold out of Amgen (AMGN) in Q4 2025, closing a stake of 2,723 shares — an estimated $768K sold.

Lawson Kroeker Investment Management first reported a position in AMGN in Q1 2023 and held it in 11 quarters. The position peaked at $989K in Q3 2024. 3,086 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Lawson Kroeker Investment Management reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Lawson Kroeker Investment Management sold 2,723 Amgen shares in Q4 2025, an estimated $768K.
  • Lawson Kroeker Investment Management first reported a position in Amgen in Q1 2023 and held it in 11 quarters.
  • Lawson Kroeker Investment Management's Amgen position peaked at $989K in Q3 2024.
  • 3,086 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Lawson Kroeker Investment Management's 13F filing for Q4 2025, filed 20 Jan 2026.